EGFR Inhibitors
Santa Cruz Biotechnology now offers a broad range of EGFR Inhibitors. The EGF receptor family comprises several related receptor tyrosine kinases that are frequently overexpressed in a variety of carcinomas. Upregulation of EGFR is associated with tumor progression. Abrogation of EGFR may be achieved with the use of EGFR Inhibitors with potential results in cell cycle arrest, apoptosis or dedifferentiation of cancer cells. EGFR Inhibitors offered by Santa Cruz inhibit EGFR and, in some cases, other receptor tyrosine kinases and tumor progression related proteins. View detailed EGFR Inhibitor specifications, including EGFR Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 1 to 10 of 98 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
Erlotinib Hydrochloride (CAS 183319-69-9) is a chemical compound known for its role as an inhibitor of EGFR (Epidermal Growth Factor Receptor). By targeting EGFR, it interferes with cellular signaling pathways, which may have significant implications in various biological processes. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib (CAS 184475-35-2) is a chemical compound known for its inhibitory action on the EGFR (Epidermal Growth Factor Receptor). By targeting EGFR, it interferes with specific cell signaling pathways, potentially affecting cellular processes in which EGFR is involved. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG-490 (CAS 133550-30-8) is a chemical compound known for its inhibitory action on EGFR (Epidermal Growth Factor Receptor). It hinders the activity of EGFR, a crucial receptor involved in cell signaling pathways, without mentioning any specific clinical or drug-related applications. | ||||||
Lapatinib ditosylate | 388082-78-8 | sc-202205B sc-202205 sc-202205A | 5 mg 10 mg 25 mg | $49.00 $77.00 $117.00 | 15 | |
Lapatinib ditosylate (CAS 388082-78-8) is a chemical compound known for its inhibitory effects on EGFR (epidermal growth factor receptor). It interferes with the function of this receptor, affecting certain cellular signaling pathways. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
Tyrphostin AG 1478 (CAS 175178-82-2) is a chemical compound known for its role as an EGFR inhibitor. It effectively hinders the activity of the EGFR (Epidermal Growth Factor Receptor), a protein involved in cell growth and proliferation. By targeting EGFR, it modulates cell signaling pathways, potentially impacting various cellular processes. | ||||||
CL-387,785 | 194423-06-8 | sc-221429 | 1 mg | $134.00 | 1 | |
CL-387,785 (CAS 194423-06-8) is a chemical compound known for its inhibitory action on the Epidermal Growth Factor Receptor (EGFR). As an EGFR inhibitor, it modulates the activity of this receptor, which plays a crucial role in cell growth and proliferation pathways. This chemical's capability to hinder EGFR function makes it an important subject of scientific research. | ||||||
Hypericin | 548-04-9 | sc-3530 sc-3530A | 1 mg 5 mg | $66.00 $214.00 | 11 | |
Hypericin (CAS 548-04-9) is a chemical compound that acts as an inhibitor of EGFR (Epidermal Growth Factor Receptor), a crucial protein involved in cell signaling and growth regulation. Through its inhibitory effects on EGFR, Hypericin can interfere with cellular processes and may have implications in various fields of research. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
Specifically designed for T790M mutation, a common resistance mutation to first-generation EGFR inhibitors. Osimertinib selectively targets both EGFR-sensitizing and T790M resistance mutations. | ||||||
Erbstatin Analog | 63177-57-1 | sc-200511 sc-200511A | 5 mg 25 mg | $83.00 $305.00 | 4 | |
Erbstatin Analog (CAS 63177-57-1) is a chemical compound known for its ability to act as an inhibitor of EGFR (Epidermal Growth Factor Receptor). It interferes with the activity of EGFR, a key signaling protein, thereby potentially affecting cellular processes influenced by this receptor. | ||||||
CGP-74514A hydrochloride | 1173021-98-1 | sc-300344 sc-300344A | 5 mg 25 mg | $235.00 $834.00 | 1 | |
CGP-74514A hydrochloride (CAS 1173021-98-1) is a chemical compound known for its inhibitory action on the Epidermal Growth Factor Receptor (EGFR). By targeting EGFR, it modulates cellular signaling pathways involved in cell growth and proliferation. Its interactions with EGFR make it a subject of interest in various research areas. | ||||||